In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.

The industry for hydrogen made with renewably generated electricity is in its infancy, which could be good for patient buy-and-hold investors willing to wait out some growing pains. Uncertainty ...

A deep dive into the chaotic circumstances the Australian manager has had to handle and whether the criticism being directed his way is fair and just.

Politics / Q&A / Jamie Raskin lays out the legal strategy to oppose Trump but says, “We’re not going to sue our way out of a ...

Anna Cathcart will be back as Kitty Song in a now confirmed third season of XO, Kitty.

Following the Chinese New Year celebrations, the first week of February 2025 saw a slight uptick in global air freight ...

South Korea will thoroughly review non-tariff barriers and other vulnerabilities to respond to a U.S. plan to introduce ...

Lee Jae-myung says he would support President Donald Trump’s efforts to restart talks with North Korea — and even consider ...

Despite spending more than $200 billion on pro-natal initiatives since 2006, South Korea has the world's lowest birth rate.

Because of the very long delay of One UI 7, Samsung will no longer have the time to develop and release One UI 7.1 along with ...

In the current global market landscape, investors are navigating a complex mix of tariff uncertainties and fluctuating economic indicators. With U.S. job growth falling short of expectations and major ...

We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...